Global Pharmaceuticals & Biotech Undervalued Dividend Payers

Johnson & Johnson

Market Cap: US$592.4b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Roche Holding

Market Cap: CHF 298.4b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Merck

Market Cap: US$307.3b

Operates as a healthcare company worldwide.

Gilead Sciences

Market Cap: US$185.9b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Sanofi

Market Cap: €97.3b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

CSL

Market Cap: AU$69.8b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Daiichi Sankyo Company

Market Cap: JP¥5.5t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Astellas Pharma

Market Cap: JP¥4.5t

Manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally.

CSPC Pharmaceutical Group

Market Cap: HK$115.0b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥101.0b

Engages in the pharmaceutical business in China.

Orion Oyj

Market Cap: €9.7b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Qiagen

Market Cap: US$9.8b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥47.8b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

H. Lundbeck

Market Cap: DKK 38.2b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Dong-E-E-JiaoLtd

Market Cap: CN¥35.4b

Engages in the research, development, production, and sale of donkey-hide gelatin and other Chinese patent medicines in China.

Hikma Pharmaceuticals

Market Cap: UK£3.7b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

Livzon Pharmaceutical Group

Market Cap: CN¥28.5b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

China Resources Pharmaceutical Group

Market Cap: HK$29.2b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Santen Pharmaceutical

Market Cap: JP¥554.6b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

Grand Pharmaceutical Group

Market Cap: HK$26.8b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

Tasly Pharmaceutical Group

Market Cap: CN¥21.9b

Researches, develops, manufactures, and sells medicines and related pharmaceuticals in China and internationally.

Kalbe Farma

Market Cap: Rp48.0t

Develops, manufactures, and trades in pharmaceutical products in Indonesia.

Dermapharm Holding

Market Cap: €2.1b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Lotus Pharmaceutical

Market Cap: NT$75.6b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

China Resources Jiangzhong PharmaceuticalLtd

Market Cap: CN¥15.6b

Engages in the manufacture of pharmaceutical products in China.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥15.6b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Tecan Group

Market Cap: CHF 1.7b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

KPC PharmaceuticalsInc

Market Cap: CN¥9.3b

A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.

Wuhan Keqian BiologyLtd

Market Cap: CN¥7.6b

Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.

SSY Group

Market Cap: HK$8.4b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Genomma Lab Internacional. de

Market Cap: Mex$16.9b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Duopharma Biotech Berhad

Market Cap: RM 1.4b

An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.